☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
94-3125814
|
|
(State or other jurisdiction of
incorporation or organization)
|
(IRS Employer
Identification No.)
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
Common Stock ($0.001 par value)
|
IVAC
|
The Nasdaq Stock Market LLC (Nasdaq) Global Select
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☒
|
|||
Non-accelerated
filer
|
☐
|
Smaller reporting company
|
☒
|
|||
Emerging growth company
|
☐
|
No.
|
Page
|
|||||
Item 1.
|
||||||
Condensed Consolidated Balance Sheets | 3 | |||||
Condensed Consolidated Statements of Operations | 4 | |||||
Condensed Consolidated Statements of Comprehensive Loss | 5 | |||||
Condensed Consolidated Statements of Cash Flows | 6 | |||||
Notes to Condensed Consolidated Financial Statements | 7 | |||||
Item 2.
|
21 | |||||
Item 3.
|
28 | |||||
Item 4.
|
28 | |||||
Item 1.
|
29 | |||||
Item 1A.
|
29 | |||||
Item 2.
|
35 | |||||
Item 3.
|
35 | |||||
Item 4.
|
35 | |||||
Item 5.
|
35 | |||||
Item 6.
|
36 | |||||
37 |
Item 1.
|
Financial Statements
|
April 3,
2021
|
January 2,
2021
|
|||||||
(Unaudited)
|
||||||||
(In thousands, except par value)
|
||||||||
ASSETS
|
|
|||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$ | 32,816 | $ | 29,341 | ||||
Short-term investments
|
16,077 | 14,839 | ||||||
Trade and other accounts receivable, net of allowances of $0 at both April 3, 2021 and January 2, 2021
|
18,229 | 28,646 | ||||||
Inventories
|
20,501 | 21,689 | ||||||
Prepaid expenses and other current assets
|
1,789 | 1,893 | ||||||
|
|
|
|
|||||
Total current assets
|
89,412 | 96,408 | ||||||
Long-term investments
|
3,919 | 5,388 | ||||||
Restricted cash
|
787 | 787 | ||||||
Property, plant and equipment, net
|
10,456 | 11,004 | ||||||
Operating lease
right-of-use-assets
|
7,582 | 8,165 | ||||||
Deferred income taxes and other long-term assets
|
5,485 | 5,486 | ||||||
|
|
|
|
|||||
Total assets
|
$ | 117,641 | $ | 127,238 | ||||
|
|
|
|
|||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|||||||
Current liabilities:
|
||||||||
Current operating lease liabilities
|
$ | 2,913 | $ | 2,853 | ||||
Accounts payable
|
2,765 | 4,259 | ||||||
Accrued payroll and related liabilities
|
5,150 | 7,679 | ||||||
Other accrued liabilities
|
3,136 | 3,598 | ||||||
Customer advances
|
42 | 33 | ||||||
|
|
|
|
|||||
Total current liabilities
|
14,006 | 18,422 | ||||||
Noncurrent liabilities:
|
||||||||
Noncurrent operating lease liabilities
|
6,045 | 6,803 | ||||||
Other long-term liabilities
|
435 | 457 | ||||||
|
|
|
|
|||||
Total noncurrent liabilities
|
6,480 | 7,260 | ||||||
Stockholders’ equity:
|
||||||||
Common stock, $0.001 par value
|
24 | 24 | ||||||
Additional
paid-in
capital
|
195,364 | 193,173 | ||||||
Treasury stock, 5,087 shares at both April 3, 2021 and at January 2, 2021
|
(29,551 | ) | (29,551 | ) | ||||
Accumulated other comprehensive income
|
552 | 640 | ||||||
Accumulated deficit
|
(69,234 | ) | (62,730 | ) | ||||
|
|
|
|
|||||
Total stockholders’ equity
|
97,155 | 101,556 | ||||||
|
|
|
|
|||||
Total liabilities and stockholders’ equity
|
$ | 117,641 | $ | 127,238 | ||||
|
|
|
|
Three Months Ended
|
||||||||
April 3,
2021
|
March 28,
2020
|
|||||||
(Unaudited)
|
||||||||
(In thousands, except per
share amounts) |
||||||||
Net revenues:
|
||||||||
Systems and components
|
$ | 13,060 | $ | 13,836 | ||||
Technology development
|
3,181 | 5,004 | ||||||
|
|
|
|
|||||
Total net revenues
|
16,241 | 18,840 | ||||||
Cost of net revenues:
|
||||||||
Systems and components
|
9,964 | 7,767 | ||||||
Technology development
|
3,223 | 2,917 | ||||||
|
|
|
|
|||||
Total cost of net revenues
|
13,187 | 10,684 | ||||||
|
|
|
|
|||||
Gross profit
|
3,054 | 8,156 | ||||||
Operating expenses:
|
||||||||
Research and development
|
3,625 | 3,284 | ||||||
Selling, general and administrative
|
5,930 | 5,972 | ||||||
|
|
|
|
|||||
Total operating expenses
|
9,555 | 9,256 | ||||||
|
|
|
|
|||||
Loss from operations
|
(6,501 | ) | (1,100 | ) | ||||
Interest income and other income (expense), net
|
29 | 142 | ||||||
|
|
|
|
|||||
Loss before provision for income taxes
|
(6,472 | ) | (958 | ) | ||||
Provision for income taxes
|
32 | 266 | ||||||
|
|
|
|
|||||
Net loss
|
$ | (6,504 | ) | $ | (1,224 | ) | ||
|
|
|
|
|||||
Net loss per share:
|
||||||||
Basic and Diluted
|
$ | (0.27 | ) | $ | (0.05 | ) | ||
Weighted average common shares outstanding:
|
||||||||
Basic and Diluted
|
24,033 | 23,483 |
Three Months Ended
|
||||||||
April 3,
2021
|
March 28,
2020
|
|||||||
(Unaudited)
|
||||||||
(In thousands)
|
||||||||
Net loss
|
$ | (6,504 | ) | $ | (1,224 | ) | ||
|
|
|
|
|||||
Other comprehensive loss, before tax:
|
||||||||
Change in unrealized net gain (loss) on
available-for-sale
|
(20 | ) | 2 | |||||
Foreign currency translation losses
|
(68 | ) | (95 | ) | ||||
|
|
|
|
|||||
Other comprehensive loss, before tax
|
(88 | ) | (93 | ) | ||||
|
|
|
|
|||||
Income tax provision related to items in other comprehensive loss
|
— | — | ||||||
|
|
|
|
|||||
Other comprehensive loss, net of tax
|
(88 | ) | (93 | ) | ||||
|
|
|
|
|||||
Comprehensive loss
|
$ | (6,592 | ) | $ | (1,317 | ) | ||
|
|
|
|
Three Months Ended
|
||||||||
April 3,
2021
|
March 28,
2020
|
|||||||
(Unaudited)
|
||||||||
(In thousands)
|
||||||||
Operating activities
|
||||||||
Net loss
|
$ | (6,504 | ) | $ | (1,224 | ) | ||
Adjustments to reconcile net loss to net cash provided by operating activities:
|
||||||||
Depreciation and amortization
|
791 | 858 | ||||||
Net amortization (accretion) of investment premiums and discounts
|
33 | (19 | ) | |||||
Equity-based compensation
|
968 | 672 | ||||||
Straight-line rent adjustment and amortization of lease incentives
|
(115 | ) | (74 | ) | ||||
Deferred income taxes
|
(40 | ) | 114 | |||||
Changes in operating assets and liabilities
|
7,399 | 786 | ||||||
|
|
|
|
|||||
Total adjustments
|
9,036 | 2,337 | ||||||
|
|
|
|
|||||
Net cash provided by operating activities
|
2,532 | 1,113 | ||||||
Investing activities
|
||||||||
Purchases of investments
|
(5,962 | ) | (4,242 | ) | ||||
Proceeds from sales and maturities of investments
|
6,140 | 5,530 | ||||||
Purchases of leasehold improvements and equipment
|
(243 | ) | (1,145 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used in) investing activities
|
(65 | ) | 143 | |||||
Financing activities
|
||||||||
Proceeds from issuance of common stock
|
1,096 | 950 | ||||||
Common stock repurchases
|
— | (393 | ) | |||||
Taxes paid related to net share settlement
|
(20 | ) | (36 | ) | ||||
|
|
|
|
|||||
Net cash provided by financing activities
|
1,076 | 521 | ||||||
|
|
|
|
|||||
Effect of exchange rate changes on cash and cash equivalents
|
(68 | ) | (94 | ) | ||||
|
|
|
|
|||||
Net increase in cash, cash equivalents and restricted cash
|
3,475 | 1,683 | ||||||
Cash, cash equivalents and restricted cash at beginning of period
|
30,128 | 20,554 | ||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash at end of period
|
$ | 33,603 | $ | 22,237 | ||||
|
|
|
|
1.
|
Description of Business and Basis of Presentation
|
2.
|
Revenue
|
TFE
|
Three Months Ended April 3, 2021
|
Three Months Ended March 28, 2020
|
||||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
HDD
|
DCP
|
PV
|
ASP
|
Total
|
HDD
|
PV
|
Total
|
|||||||||||||||||||||||||
Systems, upgrades and spare parts
|
$ | 3,585 | $ | — | $ | 111 | $ | 3,850 | $ | 7,546 | $ | 6,361 | $ | 208 | $ | 6,569 | ||||||||||||||||
Field service
|
1,636 | 14 | 42 | — | 1,692 | 1,393 | — | 1,393 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total TFE net revenues
|
$ | 5,221 | $ | 14 | $ | 153 | $ | 3,850 | $ | 9,238 | $ | 7,754 | $ | 208 | $ | 7,962 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||||
Photonics
|
April 3,
2021
|
March 28,
2020
|
||||||
(In thousands)
|
||||||||
Products:
|
||||||||
Military products
|
$ | 3,252 | $ | 5,365 | ||||
Commercial products
|
128 | 79 | ||||||
Repair and other services
|
442 | 430 | ||||||
|
|
|
|
|||||
Total Photonics product net revenues
|
3,822 | 5,874 |
Three Months Ended
|
||||||||
Photonics
|
April 3,
2021
|
March 28,
2020
|
||||||
(In thousands)
|
||||||||
Technology development:
|
||||||||
Firm Fixed Price (“FFP”)
|
1,804 | 4,430 | ||||||
Cost Plus Fixed Fee (“CPFF”)
|
1,377 | 574 | ||||||
Time and materials
|
— | — | ||||||
|
|
|
|
|||||
Total technology development net revenues
|
3,181 | 5,004 | ||||||
|
|
|
|
|||||
Total Photonics net revenues
|
$ | 7,003 | $ | 10,878 | ||||
|
|
|
|
Three Months Ended
|
||||||||||||||||||||||||
April 3, 2021
|
March 28, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
United States
|
$ | 367 | $ | 6,960 | $ | 7,327 | $ | 519 | $ | 10,856 | $ | 11,375 | ||||||||||||
Asia
|
5,021 | — | 5,021 | 7,443 | — | 7,443 | ||||||||||||||||||
Europe
|
3,850 | 43 | 3,893 | — | 22 | 22 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total net revenues
|
$ | 9,238 | $ | 7,003 | $ | 16,241 | $ | 7,962 | $ | 10,878 | $ | 18,840 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||||||||||||||||||||
April 3, 2021
|
March 28, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
Products transferred at a point in time
|
$ | 9,238 | $ | 442 | $ | 9,680 | $ | 7,962 | $ | 430 | $ | 8,392 | ||||||||||||
Products and services transferred over time
|
— | 6,561 | 6,561 | — | 10,448 | 10,448 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | 9,238 | $ | 7,003 | $ | 16,241 | $ | 7,962 | $ | 10,878 | $ | 18,840 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
April 3,
2021
|
January 2,
2021
|
Three Months
Change
|
||||||||||
(In thousands)
|
||||||||||||
TFE:
|
||||||||||||
Contract assets:
|
||||||||||||
Accounts receivable, unbilled
|
$ | — | $ | 369 | $ | (369 | ) | |||||
|
|
|
|
|
|
|||||||
Contract liabilities:
|
||||||||||||
Deferred revenue
|
$ | 276 | $ | 482 | $ | (206 | ) | |||||
Customer advances
|
42 | 33 | 9 | |||||||||
|
|
|
|
|
|
|||||||
$ | 318 | $ | 515 | $ | (197 | ) | ||||||
|
|
|
|
|
|
|||||||
Photonics:
|
||||||||||||
Contract assets:
|
||||||||||||
Accounts receivable, unbilled
|
$ | 4,689 | $ | 5,439 | $ | (750 | ) | |||||
Retainage
|
130 | 126 | 4 | |||||||||
|
|
|
|
|
|
|||||||
$ | 4,819 | $ | 5,565 | $ | (746 | ) | ||||||
|
|
|
|
|
|
|||||||
Contract liabilities:
|
||||||||||||
Deferred revenue
|
$ | 1,126 | $ | 779 | $ | 347 | ||||||
|
|
|
|
|
|
3.
|
Inventories
|
April 3,
2021 |
January 2,
2021 |
|||||||
(In thousands)
|
||||||||
Raw materials
|
$ | 10,422 | $ | 9,999 | ||||
Work-in-progress
|
5,885 | 4,832 | ||||||
Finished goods
|
4,194 | 6,858 | ||||||
|
|
|
|
|||||
$ | 20,501 | $ | 21,689 | |||||
|
|
|
|
4.
|
Equity-Based Compensation
|
Three Months Ended
|
||||||||
April 3, 2021
|
March 28, 2020
|
|||||||
(In thousands)
|
||||||||
Equity-based compensation by type of award:
|
||||||||
Stock options
|
$ | 75 | $ | 215 | ||||
RSUs
|
543 | 366 | ||||||
Employee stock purchase plan
|
350 | 91 | ||||||
|
|
|
|
|||||
Total equity-based compensation
|
$ | 968 | $ | 672 | ||||
|
|
|
|
Shares
|
Weighted-Average
Exercise Price
|
|||||||
Options outstanding at January 2, 2021
|
1,814,467 | $ | 6.66 | |||||
Options granted
|
— | $ | — | |||||
Options cancelled and forfeited
|
(50,250 | ) | $ | 8.32 | ||||
Options exercised
|
(28,399 | ) | $ | 6.78 | ||||
|
|
|||||||
Options outstanding at April 3, 2021
|
1,735,818 | $ | 6.60 | |||||
|
|
|||||||
Options exercisable at April 3, 2021
|
1,317,348 | $ | 6.71 |
|
|
Three Months Ended
|
||||||
|
|
April 3, 2021
|
|
|
March 28, 2020
|
|
||
Stock Options:
|
|
|
||||||
Weighted-average fair value of grants per share
|
|
|
—
|
|
|
$
|
1.82
|
|
Expected volatility
|
|
|
—
|
|
|
|
46.06
|
%
|
Risk-free interest rate
|
|
|
—
|
|
|
|
0.44
|
%
|
Expected term of options (in years)
|
|
|
—
|
|
|
|
4.39
|
|
Dividend yield
|
|
|
—
|
|
|
|
None
|
|
ESPP Purchase Rights:
|
|
|
||||||
Weighted-average fair value of grants per share
|
|
$
|
2.69
|
|
|
$
|
1.66
|
|
Expected volatility
|
|
|
58.56
|
%
|
|
|
36.69
|
%
|
Risk-free interest rate
|
|
|
0.08
|
%
|
|
|
1.56
|
%
|
Expected term of purchase rights (in years)
|
|
|
1.0
|
|
|
|
0.5
|
|
Dividend yield
|
|
|
None
|
|
|
|
None
|
|
|
|
Shares
|
|
|
Weighted-Average
Grant Date
Fair Value
|
|
||
Non-vested
|
|
|
901,634
|
|
|
$
|
5.30
|
|
Granted
|
|
|
9,603
|
|
|
$
|
6.45
|
|
Vested
|
|
|
(9,320
|
)
|
|
$
|
6.72
|
|
Cancelled and forfeited
|
|
|
(11,051
|
)
|
|
$
|
5.36
|
|
|
|
|
|
|
||||
Non-vested
|
|
|
890,866
|
|
|
$
|
5.29
|
|
|
|
|
|
|
5.
|
Warranty
|
Three Months
Ended |
||||||||
April 3,
2021
|
March 28,
2020
|
|||||||
(In thousands)
|
||||||||
Opening balance
|
$ | 480 | $ | 1,022 | ||||
Expenditures incurred under warranties
|
(199 | ) | (120 | ) | ||||
Accruals for product warranties issued during the reporting period
|
275 | 25 | ||||||
Adjustments to previously existing warranty accruals
|
34 | (202 | ) | |||||
|
|
|
|
|||||
Closing balance
|
$ | 590 | $ | 725 | ||||
|
|
|
|
April 3
|
January 2,
|
|||||||
2021
|
2021
|
|||||||
(In thousands)
|
||||||||
Other accrued liabilities
|
$ | 537 | $ | 405 | ||||
Other long-term liabilities
|
53 | 75 | ||||||
|
|
|
|
|||||
Total warranty provision
|
$ | 590 | $ | 480 | ||||
|
|
|
|
6.
|
Guarantees
|
7.
|
Cash, Cash Equivalents and Investments
|
April 3, 2021
|
||||||||||||||||
Amortized Cost
|
Unrealized
Holding Gains
|
Unrealized
Holding Losses |
Fair Value
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Cash and cash equivalents:
|
||||||||||||||||
Cash
|
$ | 27,929 | $ | — | $ | — | $ | 27,929 | ||||||||
Money market funds
|
4,387 | — | — | 4,387 | ||||||||||||
Certificates of deposit
|
500 | — | — | 500 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents
|
$ | 32,816 | $ | — | $ | — | $ | 32,816 | ||||||||
Short-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 6,750 | $ | 1 | $ | — | $ | 6,751 | ||||||||
Corporate bonds and medium-term notes
|
4,714 | 3 | — | 4,717 | ||||||||||||
Municipal bonds
|
595 | — | — | 595 | ||||||||||||
U.S. treasury and agency securities
|
3,998 | 16 | — | 4,014 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments
|
$ | 16,057 | $ | 20 | $ | — | $ | 16,077 | ||||||||
Long-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 500 | $ | — | $ | 2 | $ | 498 | ||||||||
Corporate bonds and medium-term notes
|
2,012 | — | 1 | 2,011 | ||||||||||||
U.S. treasury and agency securities
|
1,409 | 1 | — | 1,410 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total long-term investments
|
$ | 3,921 | $ | 1 | $ | 3 | $ | 3,919 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, and investments
|
$ | 52,794 | $ | 21 | $ | 3 | $ | 52,812 | ||||||||
|
|
|
|
|
|
|
|
January 2, 2021
|
||||||||||||||||
Amortized Cost
|
Unrealized
Holding Gains
|
Unrealized
Holding Losses
|
Fair Value
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Cash and cash equivalents:
|
||||||||||||||||
Cash
|
$ | 24,729 | $ | — | $ | — | $ | 24,729 | ||||||||
Money market funds
|
3,612 | — | — | 3,612 | ||||||||||||
Certificates of deposit
|
1,000 | — | — | 1,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents
|
$ | 29,341 | $ | — | $ | — | $ | 29,341 | ||||||||
Short-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 6,450 | $ | 2 | $ | — | $ | 6,452 | ||||||||
Commercial paper
|
500 | — | — | 500 | ||||||||||||
Corporate bonds and medium-term notes
|
2,929 | 6 | — | 2,935 | ||||||||||||
Municipal bonds
|
400 | — | — | 400 | ||||||||||||
U.S. treasury and agency securities
|
4,527 | 25 | — | 4,552 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments
|
$ | 14,806 | $ | 33 | $ | — | $ | 14,839 | ||||||||
Long-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 500 | $ | — | $ | — | $ | 500 | ||||||||
Corporate bonds and medium-term notes
|
3,474 | 4 | — | 3,478 | ||||||||||||
U.S. treasury and agency securities
|
1,409 | 1 | — | 1,410 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total long-term investments
|
$ | 5,383 | $ | 5 | $ | — | $ | 5,388 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, and investments
|
$ | 49,530 | $ | 38 | $ | — | $ | 49,568 | ||||||||
|
|
|
|
|
|
|
|
Amortized Cost
|
Fair Value
|
|||||||
(In thousands)
|
||||||||
Due in one year or less
|
$ | 20,944 | $ | 20,964 | ||||
Due after one through five years
|
3,921 | 3,919 | ||||||
|
|
|
|
|||||
$ | 24,865 | $ | 24,883 | |||||
|
|
|
|
April 3, 2021
|
||||||||||||||||
In Loss Position for
Less than 12 Months
|
In Loss Position for
Greater than 12 Months
|
|||||||||||||||
Fair Value
|
Gross
Unrealized
Losses
|
Fair Value
|
Gross
Unrealized
Losses
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Certificates of deposit
|
$ | 1,498 | $ | 2 | $ | — | $ | — | ||||||||
Corporate bonds and medium-term notes
|
2,686 | 1 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 4,184 | $ | 3 | $ | — | $ | — | |||||||||
|
|
|
|
|
|
|
|
Fair Value Measurements
at April 3, 2021
|
||||||||||||
Total
|
Level 1
|
Level 2
|
||||||||||
(In thousands)
|
||||||||||||
Recurring fair value measurements:
|
||||||||||||
Available-for-sale
|
||||||||||||
Money market funds
|
$ | 4,387 | $ | 4,387 | $ | — | ||||||
U.S. treasury and agency securities
|
5,424 | 5,424 | — | |||||||||
Certificates of deposit
|
7,749 | — | 7,749 | |||||||||
Corporate bonds and medium-term notes
|
6,728 | — | 6,728 | |||||||||
Municipal bonds
|
595 | — | 595 | |||||||||
|
|
|
|
|
|
|||||||
Total recurring fair value measurements
|
$ | 24,883 | $ | 9,811 | $ | 15,072 | ||||||
|
|
|
|
|
|
8.
|
Derivative Instruments
|
Notional Amounts
|
Derivative Liabilities
|
|||||||||||||||||||||||
Derivative Instrument
|
April 3,
2021
|
January 2,
2021
|
April 3,
2021
|
January 2,
2021
|
||||||||||||||||||||
Balance
Sheet
Line
|
Fair
Value
|
Balance
Sheet
Line
|
Fair
Value
|
|||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
Undesignated Hedges:
|
||||||||||||||||||||||||
Forward Foreign Currency Contracts
|
$ | 594 | 983 |
*
|
$ | 1 |
*
|
$ | 3 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Total Hedges
|
$ | 594 | 983 | $ | 1 | $ | 3 | |||||||||||||||||
|
|
|
|
|
|
|
|
* |
Other accrued liabilities
|
Three Months Ended April 3, 2021
|
||||||||||||||||||||
Common
Stock and
Additional
Paid-in
Capital
|
Treasury
Stock
|
Accumulated
Other
Comprehensive
Income
|
Accumulated
Deficit
|
Total
Stockholders’
Equity
|
||||||||||||||||
Balance at January 2, 2021
|
$ | 193,197 | $ | (29,551 | ) | $ | 640 | $ | (62,730 | ) | $ | 101,556 | ||||||||
Common stock issued under employee plans
|
1,223 | — | — | — | 1,223 | |||||||||||||||
Equity-based compensation expense
|
968 | — | — | — | 968 | |||||||||||||||
Net loss
|
— | — | — | (6,504 | ) | (6,504 | ) | |||||||||||||
Other comprehensive loss
|
— | — | (88 | ) | — | (88 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at April 3, 2021
|
$ | 195,388 | $ | (29,551 | ) | $ | 552 | $ | (69,234 | ) | $ | 97,155 | ||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Three Months Ended March 28, 2020
|
||||||||||||||||||||
Common
Stock and
Additional
Paid-in
Capital
|
Treasury
Stock
|
Accumulated
Other
Comprehensive
Income
|
Accumulated
Deficit
|
Total
Stockholders’
Equity
|
||||||||||||||||
Balance at December 29, 2018
|
$ | 188,313 | $ | (29,158 | ) | $ | 424 | $ | (63,786 | ) | $ | 95,793 | ||||||||
Common stock issued under employee plans
|
914 | — | — | — | 914 | |||||||||||||||
Equity-based compensation expense
|
672 | — | — | — | 672 | |||||||||||||||
Net loss
|
— | — | — | (1,224 | ) | (1,224 | ) | |||||||||||||
Other comprehensive loss
|
— | — | (93 | ) | — | (93 | ) | |||||||||||||
Common stock repurchases
|
— | (393 | ) | — | — | (393 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at March 28, 2020
|
$ | 189,899 | $ | (29,551 | ) | $ | 331 | $ | (65,010 | ) | $ | 95,669 | ||||||||
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||||||||||||||||||||
April 3, 2021
|
March 28, 2020
|
|||||||||||||||||||||||
Foreign
currency |
Unrealized
holding gains
(losses) on
available-
for-sale
investments
|
Total
|
Foreign
currency
|
Unrealized
holding gains
(losses) on
available-
for-sale
investments
|
Total
|
|||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
Beginning balance
|
$ | 602 | $ | 38 | $ | 640 | $ | 381 | $ | 43 | $ | 424 | ||||||||||||
Other comprehensive income (loss) before reclassification
|
(68 | ) | (20 | ) | (88 | ) | (95 | ) | 2 | (93 | ) | |||||||||||||
Amounts reclassified from other comprehensive income (loss)
|
— | — | — | — | — | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net current-period other comprehensive income (loss)
|
(68 | ) | (20 | ) | (88 | ) | (95 | ) | 2 | (93 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Ending balance
|
$ | 534 | $ | 18 | $ | 552 | $ | 286 | $ | 45 | $ | 331 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||||
April 3, 2021
|
March 28, 2020
|
|||||||
(In thousands, except per share amounts)
|
||||||||
Shares of common stock repurchased
|
— | 98 | ||||||
Cost of stock repurchased
|
$ | — | $ | 393 | ||||
Average price paid per share share
|
$ | — | $ | 3.97 |
10.
|
Net Loss Per Share
|
Three Months Ended
|
||||||||
April 3,
2021
|
March 28,
2020
|
|||||||
(In thousands)
|
||||||||
Net loss
|
$ | (6,504 | ) | $ | (1,224 | ) | ||
|
|
|
|
|||||
Weighted-average shares – basic
|
24,033 | 23,483 | ||||||
Effect of dilutive potential common shares
|
— | — | ||||||
|
|
|
|
|||||
Weighted-average shares – diluted
|
24,033 | 23,483 | ||||||
|
|
|
|
|||||
Net loss per share – basic and diluted
|
$ | (0.27 | ) | $ | (0.05 | ) | ||
|
|
|
|
11.
|
Segment Reporting
|
Three Months Ended
|
||||||||
April 3,
2021
|
March 28,
2020
|
|||||||
(In thousands)
|
||||||||
TFE
|
$ | 9,238 | $ | 7,962 | ||||
Photonics
|
7,003 | 10,878 | ||||||
|
|
|
|
|||||
Total segment net revenues
|
$ | 16,241 | $ | 18,840 | ||||
|
|
|
|
Three Months Ended
|
||||||||
April 3,
2021
|
March 28,
2020
|
|||||||
(In thousands)
|
||||||||
TFE
|
$ | (4,002 | ) | $ | (2,531 | ) | ||
Photonics
|
(1,146 | ) | 2,912 | |||||
|
|
|
|
|||||
Total segment operating income (loss)
|
(5,148 | ) | 381 | |||||
Unallocated costs
|
(1,353 | ) | (1,481 | ) | ||||
|
|
|
|
|||||
Loss from operations
|
(6,501 | ) | (1,100 | ) | ||||
Interest income and other income (expense), net
|
29 | 142 | ||||||
|
|
|
|
|||||
Loss before provision for income taxes
|
$ | (6,472 | ) | $ | (958 | ) | ||
|
|
|
|
April 3,
2021
|
January 2,
2021
|
|||||||
(In thousands)
|
||||||||
TFE
|
$ | 33,042 | $ | 44,335 | ||||
Photonics
|
21,474 | 22,923 | ||||||
|
|
|
|
|||||
Total segment assets
|
54,516 | 67,258 | ||||||
|
|
|
|
|||||
Cash, cash equivalents and investments
|
52,812 | 49,568 | ||||||
Restricted cash
|
787 | 787 | ||||||
Deferred income taxes
|
5,375 | 5,335 | ||||||
Other current assets
|
1,194 | 1,093 | ||||||
Common property, plant and equipment
|
1,355 | 1,443 | ||||||
Common operating lease
right-of-use
|
1,493 | 1,603 | ||||||
Other assets
|
109 | 151 | ||||||
|
|
|
|
|||||
Consolidated total assets
|
$ | 117,641 | $ | 127,238 | ||||
|
|
|
|
12.
|
Income Taxes
|
13.
|
Restructuring Charges
|
Three Months
Ended |
||||
April 3,
|
||||
2021
|
||||
(In thousands)
|
||||
Beginning balance
|
$ | — | ||
Provision for restructuring reserves
|
43 | |||
Cash payments made
|
(43 | ) | ||
|
|
|||
Ending balance
|
$ | — | ||
|
|
14.
|
Commitments and Contingencies
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
Three Months Ended
|
||||||||||||
April 3,
2021
|
March 28,
2020
|
Change over
prior period
|
||||||||||
(In thousands, except percentages and per share
amounts)
|
||||||||||||
Net revenues
|
$ | 16,241 | $ | 18,840 | $ | (2,599 | ) | |||||
Gross profit
|
$ | 3,054 | $ | 8,156 | $ | (5,102 | ) | |||||
Gross margin percent
|
18.8 | % | 43.3 | % | (24.5) points | |||||||
Loss from operations
|
$ | (6,501 | ) | $ | (1,100 | ) | $ | (5,401 | ) | |||
Net loss
|
$ | (6,504 | ) | $ | (1,224 | ) | $ | (5,280 | ) | |||
Net loss per diluted share
|
$ | (0.27 | ) | $ | (0.05 | ) | $ | (0.22 | ) |
Three Months Ended
|
||||||||||||
April 3,
2021
|
March 28,
2020
|
Change over
prior period
|
||||||||||
(In thousands)
|
||||||||||||
TFE
|
$ | 9,238 | $ | 7,962 | $ | 1,276 | ||||||
Photonics
|
||||||||||||
Products
|
3,822 | 5,874 | (2,052 | ) | ||||||||
Contract R&D
|
3,181 | 5,004 | (1,823 | ) | ||||||||
|
|
|
|
|
|
|||||||
7,003 | 10,878 | (3,875 | ) | |||||||||
|
|
|
|
|
|
|||||||
Total net revenues
|
$ | 16,241 | $ | 18,840 | $ | (2,599 | ) | |||||
|
|
|
|
|
|
April 3,
2021
|
January 2,
2021
|
March 28,
2020
|
||||||||||
(In thousands)
|
||||||||||||
TFE
|
$ | 4,221 | $ | 5,623 | $ | 22,386 | ||||||
Photonics
|
38,917 | 41,317 | 64,787 | |||||||||
|
|
|
|
|
|
|||||||
Total backlog
|
$ | 43,138 | $ | 46,940 | $ | 87,173 | ||||||
|
|
|
|
|
|
Three Months Ended
|
||||||||||||||||||||||||
April 3, 2021
|
March 28, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
United States
|
$ | 367 | $ | 6,960 | $ | 7,327 | $ | 519 | $ | 10,856 | $ | 11,375 | ||||||||||||
Asia
|
5,021 | — | 5,021 | 7,443 | — | 7,443 | ||||||||||||||||||
Europe
|
3,850 | 43 | 3,893 | — | 22 | 22 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total net revenues
|
$ | 9,238 | $ | 7,003 | $ | 16,241 | $ | 7,962 | $ | 10,878 | $ | 18,840 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||||||||
April 3,
2021
|
March 28,
2020
|
Change over
prior period
|
||||||||||
(In thousands, except percentages)
|
||||||||||||
TFE gross profit
|
$ | 2,134 | $ | 3,500 | $ | (1,366 | ) | |||||
% of TFE net revenues
|
23.1 | % | 44.0 | % | ||||||||
Photonics gross profit
|
$ | 920 | $ | 4,656 | $ | (3,736 | ) | |||||
% of Photonics net revenues
|
13.1 | % | 42.8 | % | ||||||||
Total gross profit
|
$ | 3,054 | $ | 8,156 | $ | (5,102 | ) | |||||
% of net revenues
|
18.8 | % | 43.3 | % |
Three Months Ended
|
||||||||||||
April 3,
2021
|
March 28,
2020
|
Change over
prior period
|
||||||||||
(In thousands)
|
||||||||||||
Research and development expense
|
$ | 3,625 | $ | 3,284 | $ | 341 |
Three Months Ended
|
||||||||||||
April 3,
2021
|
March 28,
2020
|
Change over
prior period
|
||||||||||
(In thousands)
|
||||||||||||
Selling, general and administrative expense
|
$ | 5,930 | $ | 5,972 | $ | (42 | ) |
Three Months Ended
|
||||||||||||
April 3,
2021
|
March 28,
2020
|
Change over
prior period
|
||||||||||
(In thousands)
|
||||||||||||
Interest income and other income (expense), net
|
$ | 29 | $ | 142 | $ | (113 | ) |
Three Months Ended
|
||||||||||||
April 3,
2021
|
March 28,
2020
|
Change over
prior period
|
||||||||||
(In thousands)
|
||||||||||||
Income tax provision
|
$ | 32 | $ | 266 | $ | (234 | ) |
April 3,
2021
|
January 2,
2021
|
|||||||
(In thousands)
|
||||||||
Cash and cash equivalents
|
$ | 32,816 | $ | 29,341 | ||||
Restricted cash
|
787 | 787 | ||||||
Short-term investments
|
16,077 | 14,839 | ||||||
Long-term investments
|
3,919 | 5,388 | ||||||
|
|
|
|
|||||
Total cash, cash equivalents, restricted cash and investments
|
$ | 53,599 | $ | 50,355 | ||||
|
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|